Impaired inhibitory processing: a new therapeutic target for autism and psychosis?

Heinze K
Howes EK
Ramaswami M
Broome MR

Scientific Abstract

In the healthy brain, homeostatic balance between excitation and inhibition maintains neural stability. Reduced inhibition may explain shared symptoms observed in autism and psychosis. Here we review evidence suggesting that altered levels of gamma-aminobutyric acid (GABA) may underlie both disorders, providing a potential cross-diagnostic therapeutic target.

Similar content

Preprint
Causse AA, Curot J, Lopes-Dos-Santos V, Nunes-da-Silva R, Barron HC, Dornier V, Denuelle M, De Barros A, Sol J, Lotterie J, Lehongre K, Fernandez-Vidal S, Frazzini V, Navarro V, Valton L, Barbeau EJ, Denison T, Reddy L, Dupret D

A learning-evoked slow-oscillatory architecture paces population activity for offline reactivation across the human medial temporal lobe

Impaired inhibitory processing: a new therapeutic target for autism and psychosis?

Heinze K
Howes EK
Ramaswami M
Broome MR

Scientific Abstract

In the healthy brain, homeostatic balance between excitation and inhibition maintains neural stability. Reduced inhibition may explain shared symptoms observed in autism and psychosis. Here we review evidence suggesting that altered levels of gamma-aminobutyric acid (GABA) may underlie both disorders, providing a potential cross-diagnostic therapeutic target.

Citation

2021. Br J Psychiatry, 218(6):295-298.

DOI

10.1192/bjp.2020.163

Free Full Text at Europe PMC

PMC7612604

Downloads

View PDF (1MB)

Similar content

Preprint
Causse AA, Curot J, Lopes-Dos-Santos V, Nunes-da-Silva R, Barron HC, Dornier V, Denuelle M, De Barros A, Sol J, Lotterie J, Lehongre K, Fernandez-Vidal S, Frazzini V, Navarro V, Valton L, Barbeau EJ, Denison T, Reddy L, Dupret D

A learning-evoked slow-oscillatory architecture paces population activity for offline reactivation across the human medial temporal lobe